Interpace Biosciences (IDXG, $1.16) was a top loser yesterday, declining -1 to $1.16 per share. Of the 402 stocks analyzed in the Medical Specialties Industry, of them () exhibited an Uptrend while of them () were in a Downtrend. 54 similar cases when IDXG's price dropped within one day were found. In of those 54 cases, IDXG's price went up during the following month. Based on these historical data, the odds of a Downtrend reversal for IDXG are